Abstract
In many autoimmune diseases, autoantigen-specific Th17 cells play a pivotal role in disease pathogenesis. Th17 cells can transdifferentiate into other T cell subsets in inflammatory conditions, however, there have been no attempts to target Th17 cell plasticity using vaccines. We investigated if autoantigen-specific Th17 cells could be specifically targeted using a therapeutic vaccine approach, where antigen was formulated in all-trans retinoic acid (ATRA)-containing liposomes, permitting co-delivery of antigen and ATRA to the same target cell. Whilst ATRA was previously found to broadly reduce Th17 responses, we found that antigen formulated in ATRA-containing cationic liposomes only inhibited Th17 cells in an antigen-specific manner and not when combined with an irrelevant antigen. Furthermore, this approach shifted existing Th17 cells away from IL-17A expression and transcriptomic analysis of sorted Th17 lineage cells from IL-17 fate reporter mice revealed a shift of antigen-specific Th17 cells to exTh17 cells, expressing functional markers associated with T cell regulation and tolerance. In the experimental autoimmune encephalomyelitis (EAE) mouse model of MS, vaccination with myelin-specific (MOG) antigen in ATRA-containing liposomes reduced Th17 responses and alleviated disease. This highlights the potential of therapeutic vaccination for changing the phenotype of existing Th17 cells in the context of immune mediated diseases.
| Original language | English |
|---|---|
| Article number | 103174 |
| Journal | Journal of Autoimmunity |
| Volume | 144 |
| Number of pages | 11 |
| ISSN | 0896-8411 |
| DOIs | |
| Publication status | Published - Apr 2024 |
Bibliographical note
Publisher Copyright:© 2024 The Authors
Funding
We wish to acknowledge the excellent assistance received from Rune Fledelius Jensen and Julia Sid Hansen at the Department of Infectious Disease Immunology at Statens Serum Institut. Furthermore, we are grateful to the experimental animal facilities at Statens Serum Institut for animal handling and in particular to Tia Maria Villumsen, Nete Junkuhn Rosendal and Sabina Christina Köppä Altenburg for their help with breeding of the IL-17A fate reporter mice stain. In addition, we wish to acknowledge Redoxis (Lund, Sweden) and CD Genomics (NY, USA) for running the EAE experiment and bulk RNA sequencing, respectively. We wish to thank Noah Perlmutter from the University of California for assistance with the EAE model. All figures were created with Biorender.com. The study was supported by Independent Research Fund Denmark (FTP1, grant no. 9041-00160B) to G.K.P, a Novo Nordisk Foundation Pioneer Innovator grant (grant no. 0068804) to D.C. and G.K.P. a National Institute of Health grant (no. K08AR072144) to J.F.A. a UCSF Center for the Rheumatic Diseases grant to J.F.A and Nora Eccles Treadwell Foundation to J.F.A. We wish to acknowledge the excellent assistance received from Rune Fledelius Jensen and Julia Sid Hansen at the Department of Infectious Disease Immunology at Statens Serum Institut. Furthermore, we are grateful to the experimental animal facilities at Statens Serum Institut for animal handling and in particular to Tia Maria Villumsen, Nete Junkuhn Rosendal and Sabina Christina Köppä Altenburg for their help with breeding of the IL-17A fate reporter mice stain. In addition, we wish to acknowledge Redoxis (Lund, Sweden) and CD Genomics (NY, USA) for running the EAE experiment and bulk RNA sequencing, respectively. We wish to thank Noah Perlmutter from the University of California for assistance with the EAE model. All figures were created with Biorender.com . The study was supported by Independent Research Fund Denmark (FTP1, grant no. 9041-00160B ) to G.K.P, a Novo Nordisk Foundation Pioneer Innovator grant (grant no. 0068804 ) to D.C. and G.K.P., a National Institute of Health grant (no. K08AR072144 ) to J.F.A., a UCSF Center for the Rheumatic Diseases grant to J.F.A and Nora Eccles Treadwell Foundation to J.F.A.
Keywords
- All-trans-retinoic acid (ATRA)
- CAF16
- Experimental encephalomyelitis model (EAE)
- IL-17A fate reporter mice
- Th17 cells
- Therapeutic vaccine
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS